Trials / Active Not Recruiting
Active Not RecruitingNCT04106908
Effectiveness and Tolerability of Eqwilate in Real-life Conditions
MOdalities of Use, effectiveNEss and TOlerability of Eqwilate® a Balanced combInatiON of VWF and FVIII in Von WillEbrand Patients in Real-life Conditions: the ONE-TO-ONE Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (actual)
- Sponsor
- Octapharma · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- —
Summary
MOdalities of use, effectiveNEss and TOlerability of Eqwilate® a balanced combInatiON of VWF and FVIII in von WillEbrand patients in real-life conditions: the ONE-TO-ONE study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Eqwilate | Eqwilate® is a new generation, albumin-free, high-purity, double virus-inactivated, freezedried concentrate of VWF and FVIII |
Timeline
- Start date
- 2019-11-27
- Primary completion
- 2024-05-11
- Completion
- 2026-11-01
- First posted
- 2019-09-27
- Last updated
- 2025-04-18
Locations
9 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04106908. Inclusion in this directory is not an endorsement.